MedTrace Logo

Parathyroid Tumor Clonal Status

NCT05997810 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 839

Last updated 2026-05-12

No results posted yet for this study

Summary

To define the frequency of monoclonal-X and polyclonal-X tumors in hyperparathyroid disorders patients having PTX and to define the relationship between parathyroid tumor clonal status and multiple gland neoplasia (MGN), we will compare surgical and pathologic outcomes to tumor clonal status in a multicenter cohort of patients having bilateral neck exploration (BNE) and PTX (primary objectives).

Conditions

  • Parathyroid Tumor
  • Primary Hyperparathyroidism
  • Secondary Hyperparathyroidism (SHPT)
  • Tertiary Hyperparathyroidism

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-28
Primary Completion
2031-01-31
Completion
2032-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05997810 on ClinicalTrials.gov